Previous close | 4.98 |
Open | 5.30 |
Bid | 5.18 x 1100 |
Ask | 5.24 x 1000 |
Day's range | 4.78 - 5.58 |
52-week range | 4.41 - 26.75 |
Volume | |
Avg. volume | 4,650,370 |
Market cap | 2.133B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Agilon Health reports significant membership and revenue increases, while navigating operational adjustments and market uncertainties.
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Comprehensive Analysis of Agilon Health's First Quarter Financials and Strategic Initiatives